- Home
- VTAK vs NDRA Comparison
VTAK vs NDRA Comparison
Compare VTAK & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTAK
- NDRA
- Stock Information
- Founded
- VTAK 2002
- NDRA 2007
- Country
- VTAK United States
- NDRA United States
- Employees
- VTAK N/A
- NDRA N/A
- Industry
- VTAK Medical/Dental Instruments
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- VTAK Health Care
- NDRA Health Care
- Exchange
- VTAK Nasdaq
- NDRA Nasdaq
- Market Cap
- VTAK 3.1M
- NDRA 3.1M
- IPO Year
- VTAK 2018
- NDRA 2017
- Fundamental
- Price
- VTAK $2.45
- NDRA $4.74
- Analyst Decision
- VTAK
- NDRA Strong Buy
- Analyst Count
- VTAK 0
- NDRA 1
- Target Price
- VTAK N/A
- NDRA $46.00
- AVG Volume (30 Days)
- VTAK 3.1M
- NDRA 27.1K
- Earning Date
- VTAK 08-11-2025
- NDRA 08-14-2025
- Dividend Yield
- VTAK N/A
- NDRA N/A
- EPS Growth
- VTAK N/A
- NDRA N/A
- EPS
- VTAK N/A
- NDRA N/A
- Revenue
- VTAK $600,000.00
- NDRA N/A
- Revenue This Year
- VTAK $822.86
- NDRA N/A
- Revenue Next Year
- VTAK $168.42
- NDRA N/A
- P/E Ratio
- VTAK N/A
- NDRA N/A
- Revenue Growth
- VTAK 37.62
- NDRA N/A
- 52 Week Low
- VTAK $2.36
- NDRA $2.90
- 52 Week High
- VTAK $33.06
- NDRA $22.68
- Technical
- Relative Strength Index (RSI)
- VTAK 39.41
- NDRA 54.47
- Support Level
- VTAK $2.36
- NDRA $4.00
- Resistance Level
- VTAK $2.55
- NDRA $4.69
- Average True Range (ATR)
- VTAK 0.14
- NDRA 0.32
- MACD
- VTAK 0.03
- NDRA 0.09
- Stochastic Oscillator
- VTAK 14.25
- NDRA 100.00
About VTAK Catheter Precision Inc.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.